Previous 10 | Next 10 |
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India Times of India article highlights CoSara's tireless efforts to increase manufacturing of COVID-19 tests in response to deadly wave of infections PR Newswire SALT LAKE C...
The institutions and companies involved in genetics now lend support to most other areas of life sciences. The contributions include the discovery of genetic markers of disease and gene therapy. The market for genetic testing continues to grow in leaps and bounds, and has gained momentum as th...
Co-Diagnostics, Inc. Test Performance Demonstrated by Australian Researchers in Peer-Reviewed Publication Paper published in the Journal of Medical Microbiology utilizes Company's test in rapidly deployable mobile molecular diagnostics PR Newswire SALT LAKE CITY ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Co-Diagnostics (NASDAQ: CODX ) stock was a much hotter, more headline-worthy play in the early innings of the pandemic. Source: Shutterstock Back then the company was swept up in the fever to get in early ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Respiratory therapy product provider Allied Healthcare Products (NASDAQ: AHPI ) hasn’t been favored by Wall Street over the past year. Indeed, it’s fair to say that AHPI stock has been beaten down &...
Co-Diagnostics, Inc. CEO Discusses Company Strategy for the Future with Yahoo! Finance PR Newswire SALT LAKE CITY , March 31, 2021 /PRNewswire/ -- The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patente...
Co-Diagnostics (NASDAQ: CODX) was one of the best-performing stocks of 2020, but a fourth-quarter earnings report failed to impress investment banks that follow the molecular diagnostics company. The stock has been under pressure since Maxim downgraded the stock to hold, and H.C. Wa...
Shares of molecular diagnostics specialist Co-Diagnostics (NASDAQ: CODX) are dropping sharply on Monday and were down by 10.3% as of 3:01 p.m. EDT, after falling by as much as 12.4% earlier today. There was no company-specific news that caused the sell-off, but we can probably attri...
The analyst concerns over COVID-19 test makers continue as Maxim Group downgraded Co-Diagnostics ([[CODX]] -9.1%) to hold from buy arguing that the stock already reflects whatever the COVID-related benefit as the vaccinations blunt the impact.The company’s Q4 2020 revenue which was ahe...
Shares of Co-Diagnostics (NASDAQ: CODX) were tanking on Friday with the stock down 14.6% as of 10:07 a.m. EDT. The big drop came after the molecular diagnostics company provided its fourth-quarter update after the market close on Thursday. Co-Diagnostics easily beat the cons...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...